Home › Funds › Nextech Invest Ltd. › SLN

Nextech Invest Ltd. position in SLN

SILENCE THERAPEUTICS PLC · Health Care

Nextech Invest Ltd. reported holding 952,400 shares of SLN (SILENCE THERAPEUTICS PLC) in its Q2 2026 13F filing — a position valued at US$10.5M, representing 0.50% of its reported portfolio and ranking #12 among its reported holdings. Nextech Invest Ltd. has disclosed SLN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)952.40K sh
Reported value held$10.46M
Portfolio Weight0.50%
First reportedQ1 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Nextech Invest Ltd.'s SLN position evolved

Nextech Invest Ltd. first disclosed a stake in SLN in Q1 2025 at 952,400 shares (US$2.7M). The position peaked in Q2 2026 at 952,400 shares, worth US$10.5M. Across 6 filings, Nextech Invest Ltd. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 952,400 shares valued at US$10.5M.

Quarter by quarter

QuarterSharesValueChange
Q1 2025 952.40K $2.69M New
Q2 2025 952.40K $5.52M Hold
Q3 2025 952.40K $4.94M Hold
Q4 2025 952.40K $5.79M Hold
Q1 2026 952.40K $5.02M Hold
Q2 2026 952.40K $10.46M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SLN and 13F data

SLN (SILENCE THERAPEUTICS PLC) is a Health Care company. 35 other funds we track also report a position in SLN — the largest reported positions include Siren, L.L.C. (US$36.4M), TCG Crossover Management, LLC (US$33.3M), Redmile Group, LLC (US$23.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SLN

All SLN fund holders →

FAQ

How long has Nextech Invest Ltd. held SLN?

Nextech Invest Ltd. has disclosed SLN holdings in 6 of the last 6 reported quarters, going back to Q1 2025.

What is Nextech Invest Ltd.'s current position in SLN?

As of Q2 2026, Nextech Invest Ltd. holds 952.40K shares of SLN (SILENCE THERAPEUTICS PLC), valued at $10.46M, representing 0.50% of its reported portfolio and ranking #12.

Has Nextech Invest Ltd. been buying or selling SLN?

In the latest 13F filing (Q2 2026), Nextech Invest Ltd. held unchanged its position in SLN. The position peaked in Q2 2026 at 952.40K shares.

Which other funds hold SLN?

Other major institutional holders of SLN include Siren, L.L.C., TCG Crossover Management, LLC, Redmile Group, LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.